Table 2 Summary of the aminosalicylate drugs used, including dose and duration of treatment
Aminosalicylate used at time of AIN | Number of cases, n | Mean daily dose, g | Median duration of therapy before renal impairment, months |
|---|---|---|---|
Mesalazine | 39 | 2.2 (n = 29) | 31.5 (n = 34) |
Sulfasalazine | 1 | 2 (n = 1) | 8 (n = 1) |
Olsalazine | 1 | 0.5 (n = 1) | 8 (n = 1) |